Document is current

Article History

Received: 17 November 2025

Accepted: 30 April 2026

First Online: 26 June 2026

Declarations

:

: The following co-authors declare no conflict of interest: AS, BP, CC, CR, CT, EC, IF, JA, JPG, JMB, JK, JV, KK, MB, MK, MI, MPRU, NPH, PB, PMV, PV, RW, SEBT, SOE, VP, YH. H. F. G. has received research grants from the Swiss National Science Foundation, Swiss HIV Cohort Study, Yvonne Jacob Foundation, NIH, Gilead, ViiV, and is a subcontractor to a Bill and Melinda Gates foundation grant, paid to his institution; personal honoraria for data safety monitoring board or advisory board consultations from Merck, ViiV healthcare, Gilead Sciences, Janssen, Johnson and Johnson, Novartis, and GSK. AR reports support to his institution for advisory boards and/or travel grants from MSD, Gilead Sciences, ViiV and Moderna, and an investigator initiated trial (IIT) grant from Gilead Sciences. All remuneration went to his home institution and not to AR personally, and all remuneration was provided outside the submitted work. MPRE has received unrestricted research grants from GlaxoSmithKline and the Swiss National Science Foundation.

: All participating studies received ethical approvals from their respective institutions and informed consent from participants. Investigators requiring access to study-specific data need to obtain ethical approval from their home institution and follow study-specific data access rules and procedures. Not applicable. This article describes the cohort framework and metadata only, without presenting individual-level results. All data used in this article is already available online at: .

: Not applicable. This article describes the cohort framework and metadata only, without presenting individual-level results. All data used in this article is already available online at: .

: Grammar proofreading was supported by ChatGPT-4 (OpenAI).